Penumbra (PEN) Research & Development (2014 - 2026)
Penumbra (PEN) reported Research & Development of $22.4 million for Q1 2026, up 1.38% year-over-year from $22.1 million in Q1 2025, and up 2.7% quarter-over-quarter from $21.8 million in Q4 2025.
Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Research & Development data on file, last reported at $22.4 million in Q1 2026.
- Research & Development for Q1 2026 came in at $22.4 million, up 1.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.1 million (down 2.35% YoY), and the FY2025 annual result was $89.8 million, down 5.29% from the prior year.
- Research & Development rose to $22.4 million in Q1 2026 per PEN's latest filing, from $21.8 million in the prior quarter.
- Over five years, Research & Development peaked at $25.2 million in Q3 2024 and troughed at $18.0 million in Q4 2022.
- A 5-year average of $21.8 million and a median of $21.8 million in 2025 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 27.41% in 2022 and fell as far as 65.46% in 2022.
- A 5-year view of Research & Development shows it stood at $18.0 million in 2022, then climbed by 22.14% to $21.9 million in 2023, then fell by 8.81% to $20.0 million in 2024, then increased by 8.92% to $21.8 million in 2025, then grew by 2.7% to $22.4 million in 2026.
- Business Quant data shows PEN's Research & Development at $22.4 million in Q1 2026, $21.8 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Penumbra | 12.45 Bn | 11.84 Bn | 253.41 Mn | 22.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 23.22 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 19.99 Mn |
| Dec 31, 2022 | 17.96 Mn |
| Sep 30, 2022 | 21.32 Mn |
| Jun 30, 2022 | 19.56 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 52.00 Mn |
| Sep 30, 2021 | 16.73 Mn |
| Jun 30, 2021 | 17.74 Mn |